Elevance Health, Inc.
ELVNYSECIK 1156039FinancialsFiscal year ends Dec 31
Reports and events: 353 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2118:14 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001156039-26-000071 |
| 2026-10-2110:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-26-000068 |
| 2026-09-1010:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001156039-26-000063 |
| 2026-07-1515:27 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001156039-26-000060 |
| 2026-07-1510:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-26-000058 |
| 2026-06-1010:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001156039-26-000049 |
| 2026-05-1320:07 ET | 8-K | 5.07 Shareholder vote results | 0001156039-26-000046 |
| 2026-04-2214:09 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001156039-26-000043 |
| 2026-04-2210:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-26-000039 |
| 2026-03-2720:21 ET | DEF 14A | Proxy statementPeriod 2026-05-13 | 0001156039-26-000031 |
| 2026-03-1010:02 ET | 8-K | 7.01 Regulation FD disclosure | 0001156039-26-000024 |
| 2026-03-0211:03 ET | 8-K | 8.01 Other events | 0001156039-26-000022 |
| 2026-02-2619:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001156039-26-000019 |
| 2026-02-0619:57 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001156039-26-000013 |
| 2026-01-2811:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-26-000006 |
| 2025-12-1021:35 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001156039-25-000142 |
| 2025-11-1022:03 ET | 8-K | 7.01 Regulation FD disclosure | 0001156039-25-000139 |
| 2025-10-2115:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001156039-25-000136 |
| 2025-10-2110:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-244191 |
| 2025-09-1520:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-203542 |
| 2025-09-0410:02 ET | 8-K | 7.01 Regulation FD disclosure | 0001156039-25-000129 |
| 2025-07-2820:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001156039-25-000118 |
| 2025-07-1719:09 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001156039-25-000114 |
| 2025-07-1710:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-25-000111 |
| 2025-05-2810:31 ET | 8-K | 7.01 Regulation FD disclosure | 0001156039-25-000096 |
| 2025-05-1421:27 ET | 8-K | 5.07 Shareholder vote results | 0001156039-25-000065 |
| 2025-04-2217:18 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001156039-25-000057 |
| 2025-04-2210:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-25-000056 |
| 2025-04-1714:24 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001156039-25-000051 |
| 2025-03-2820:20 ET | DEF 14A | Proxy statementPeriod 2025-05-14 | 0001156039-25-000046 |
| 2025-03-1020:17 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-25-050889 |
| 2025-02-2020:58 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001156039-25-000010 |
| 2025-01-2311:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-25-000007 |
| 2024-10-3120:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-248691 |
| 2024-10-1721:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001156039-24-000122 |
| 2024-10-1710:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-24-000119 |
| 2024-07-1719:01 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001156039-24-000104 |
| 2024-07-1710:09 ET | 8-K | 2.02 Results of operations | 0001156039-24-000101 |
| 2024-06-1210:07 ET | 8-K | 7.01 Regulation FD disclosure | 0001156039-24-000093 |
| 2024-05-3020:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-150440 |
| 2024-05-1521:14 ET | 8-K | 5.07 Shareholder vote results | 0001156039-24-000069 |
| 2024-04-1818:16 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001156039-24-000066 |
| 2024-04-1810:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-099824 |
| 2024-03-2920:08 ET | DEF 14A | Proxy statementPeriod 2024-05-15 | 0001156039-24-000050 |
| 2024-03-0411:07 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-24-056688 |
| 2024-02-2121:30 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001156039-24-000015 |
| 2024-01-2522:20 ET | 8-K | 8.01 Other events | 0001193125-24-015557 |
| 2024-01-2411:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-013498 |
| 2023-10-1818:43 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001156039-23-000109 |
| 2023-10-1810:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-258013 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.